Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Key observation: All dose groups began at 0.5mg with gradual escalation over several weeks before reaching maintenance doses
{2
Underlying Health Conditions: Conditions like pernicious anemia, Crohns disease, or celiac disease can affect B12 absorption and necessitate ongoing treatment
References Philippou, A., Maridaki, M., Halapas, A., & Koutsilieris, M
PAT-1251 (IUPAC name: 3-((4-(aminomethyl)-6-chloropyridin-2-yl)oxy)phenyl)((3 R ,4 R )-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone, CAS# 2098884-53-6, structure see below) was obtained from Sundia Meditech Co.Ltd, and prepared in 0.5% methyl cellulose in DI water 41
US$ 28.75
US$ 22.14
.png/:/rs=w:400,cg:true,m)
US$ 28.91
US$ 24.55
US$ 29.06
US$ 21.87
